-
1
-
-
84904055758
-
Immune cell-poor melanomas benefit from PD-1 blockade after targeted type i IFN activation
-
T. Bald, J. Landsberg, D. Lopez-Ramos, M. Renn, N. Glodde, P. Jansen, E. Gaffal, J. Steitz, R. Tolba, U. Kalinke, and et al. Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation Cancer Discov. 4 2014 674 687
-
(2014)
Cancer Discov.
, vol.4
, pp. 674-687
-
-
Bald, T.1
Landsberg, J.2
Lopez-Ramos, D.3
Renn, M.4
Glodde, N.5
Jansen, P.6
Gaffal, E.7
Steitz, J.8
Tolba, R.9
Kalinke, U.10
-
2
-
-
17644394616
-
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
-
F. Balkwill, K.A. Charles, and A. Mantovani Smoldering and polarized inflammation in the initiation and promotion of malignant disease Cancer Cell 7 2005 211 217
-
(2005)
Cancer Cell
, vol.7
, pp. 211-217
-
-
Balkwill, F.1
Charles, K.A.2
Mantovani, A.3
-
3
-
-
59549097545
-
COX-2 expression in malignant melanoma: A novel prognostic marker?
-
M.R. Becker, M.D. Siegelin, R. Rompel, A.H. Enk, and T. Gaiser COX-2 expression in malignant melanoma: a novel prognostic marker? Melanoma Res. 19 2009 8 16
-
(2009)
Melanoma Res.
, vol.19
, pp. 8-16
-
-
Becker, M.R.1
Siegelin, M.D.2
Rompel, R.3
Enk, A.H.4
Gaiser, T.5
-
4
-
-
84911937777
-
Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity
-
M.L. Broz, M. Binnewies, B. Boldajipour, A.E. Nelson, J.L. Pollack, D.J. Erle, A. Barczak, M.D. Rosenblum, A. Daud, D.L. Barber, and et al. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity Cancer Cell 26 2014 638 652
-
(2014)
Cancer Cell
, vol.26
, pp. 638-652
-
-
Broz, M.L.1
Binnewies, M.2
Boldajipour, B.3
Nelson, A.E.4
Pollack, J.L.5
Erle, D.J.6
Barczak, A.7
Rosenblum, M.D.8
Daud, A.9
Barber, D.L.10
-
5
-
-
84899080636
-
Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma
-
J.C. Castle, M. Loewer, S. Boegel, J. de Graaf, C. Bender, A.D. Tadmor, V. Boisguerin, T. Bukur, P. Sorn, C. Paret, and et al. Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma BMC Genomics 15 2014 190
-
(2014)
BMC Genomics
, vol.15
, pp. 190
-
-
Castle, J.C.1
Loewer, M.2
Boegel, S.3
De Graaf, J.4
Bender, C.5
Tadmor, A.D.6
Boisguerin, V.7
Bukur, T.8
Sorn, P.9
Paret, C.10
-
6
-
-
84939947684
-
Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection
-
J.H. Chen, C.J. Perry, Y.-C. Tsui, M.M. Staron, I.A. Parish, C.X. Dominguez, D.W. Rosenberg, and S.M. Kaech Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection Nat. Med. 21 2015 327 334
-
(2015)
Nat. Med.
, vol.21
, pp. 327-334
-
-
Chen, J.H.1
Perry, C.J.2
Tsui, Y.-C.3
Staron, M.M.4
Parish, I.A.5
Dominguez, C.X.6
Rosenberg, D.W.7
Kaech, S.M.8
-
7
-
-
84898683719
-
Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type i interferon and apoptosis in macrophages
-
F. Coulombe, J. Jaworska, M. Verway, F. Tzelepis, A. Massoud, J. Gillard, G. Wong, G. Kobinger, Z. Xing, C. Couture, and et al. Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages Immunity 40 2014 554 568
-
(2014)
Immunity
, vol.40
, pp. 554-568
-
-
Coulombe, F.1
Jaworska, J.2
Verway, M.3
Tzelepis, F.4
Massoud, A.5
Gillard, J.6
Wong, G.7
Kobinger, G.8
Xing, Z.9
Couture, C.10
-
8
-
-
84872445265
-
Neutralizing tumor-promoting chronic inflammation: A magic bullet?
-
L.M. Coussens, L. Zitvogel, and A.K. Palucka Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339 2013 286 291
-
(2013)
Science
, vol.339
, pp. 286-291
-
-
Coussens, L.M.1
Zitvogel, L.2
Palucka, A.K.3
-
9
-
-
0346368096
-
Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise
-
A.J. Dannenberg, and K. Subbaramaiah Targeting cyclooxygenase-2 in human neoplasia: rationale and promise Cancer Cell 4 2003 431 436
-
(2003)
Cancer Cell
, vol.4
, pp. 431-436
-
-
Dannenberg, A.J.1
Subbaramaiah, K.2
-
10
-
-
0035139062
-
Expression of cyclooxygenase 2 in human malignant melanoma
-
C. Denkert, M. Köbel, S. Berger, A. Siegert, A. Leclere, U. Trefzer, and S. Hauptmann Expression of cyclooxygenase 2 in human malignant melanoma Cancer Res. 61 2001 303 308
-
(2001)
Cancer Res.
, vol.61
, pp. 303-308
-
-
Denkert, C.1
Köbel, M.2
Berger, S.3
Siegert, A.4
Leclere, A.5
Trefzer, U.6
Hauptmann, S.7
-
11
-
-
63249105225
-
Oncogenic Braf induces melanocyte senescence and melanoma in mice
-
N. Dhomen, J.S. Reis-Filho, S. da Rocha Dias, R. Hayward, K. Savage, V. Delmas, L. Larue, C. Pritchard, and R. Marais Oncogenic Braf induces melanocyte senescence and melanoma in mice Cancer Cell 15 2009 294 303
-
(2009)
Cancer Cell
, vol.15
, pp. 294-303
-
-
Dhomen, N.1
Reis-Filho, J.S.2
Da Rocha Dias, S.3
Hayward, R.4
Savage, K.5
Delmas, V.6
Larue, L.7
Pritchard, C.8
Marais, R.9
-
12
-
-
80355147292
-
Type i interferon is selectively required by dendritic cells for immune rejection of tumors
-
M.S. Diamond, M. Kinder, H. Matsushita, M. Mashayekhi, G.P. Dunn, J.M. Archambault, H. Lee, C.D. Arthur, J.M. White, U. Kalinke, and et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors J. Exp. Med. 208 2011 1989 2003
-
(2011)
J. Exp. Med.
, vol.208
, pp. 1989-2003
-
-
Diamond, M.S.1
Kinder, M.2
Matsushita, H.3
Mashayekhi, M.4
Dunn, G.P.5
Archambault, J.M.6
Lee, H.7
Arthur, C.D.8
White, J.M.9
Kalinke, U.10
-
13
-
-
22144465860
-
A critical function for type i interferons in cancer immunoediting
-
G.P. Dunn, A.T. Bruce, K.C.F. Sheehan, V. Shankaran, R. Uppaluri, J.D. Bui, M.S. Diamond, C.M. Koebel, C. Arthur, J.M. White, and R.D. Schreiber A critical function for type I interferons in cancer immunoediting Nat. Immunol. 6 2005 722 729
-
(2005)
Nat. Immunol.
, vol.6
, pp. 722-729
-
-
Dunn, G.P.1
Bruce, A.T.2
Sheehan, K.C.F.3
Shankaran, V.4
Uppaluri, R.5
Bui, J.D.6
Diamond, M.S.7
Koebel, C.M.8
Arthur, C.9
White, J.M.10
Schreiber, R.D.11
-
14
-
-
84857118418
-
Expression of tumour-specific antigens underlies cancer immunoediting
-
M. DuPage, C. Mazumdar, L.M. Schmidt, A.F. Cheung, and T. Jacks Expression of tumour-specific antigens underlies cancer immunoediting Nature 482 2012 405 409
-
(2012)
Nature
, vol.482
, pp. 405-409
-
-
DuPage, M.1
Mazumdar, C.2
Schmidt, L.M.3
Cheung, A.F.4
Jacks, T.5
-
15
-
-
84874872137
-
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma
-
D.T. Frederick, A. Piris, A.P. Cogdill, Z.A. Cooper, C. Lezcano, C.R. Ferrone, D. Mitra, A. Boni, L.P. Newton, C. Liu, and et al. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma Clin. Cancer Res. 19 2013 1225 1231
-
(2013)
Clin. Cancer Res.
, vol.19
, pp. 1225-1231
-
-
Frederick, D.T.1
Piris, A.2
Cogdill, A.P.3
Cooper, Z.A.4
Lezcano, C.5
Ferrone, C.R.6
Mitra, D.7
Boni, A.8
Newton, L.P.9
Liu, C.10
-
17
-
-
84923275611
-
Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases
-
R.L. Frock, J. Hu, R.M. Meyers, Y.-J. Ho, E. Kii, and F.W. Alt Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases Nat. Biotechnol. 33 2015 179 186
-
(2015)
Nat. Biotechnol.
, vol.33
, pp. 179-186
-
-
Frock, R.L.1
Hu, J.2
Meyers, R.M.3
Ho, Y.-J.4
Kii, E.5
Alt, F.W.6
-
18
-
-
80355136945
-
Host type i IFN signals are required for antitumor CD8+ T cell responses through CD8alpha+ dendritic cells
-
M.B. Fuertes, A.K. Kacha, J. Kline, S.-R. Woo, D.M. Kranz, K.M. Murphy, and T.F. Gajewski Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8alpha+ dendritic cells J. Exp. Med. 208 2011 2005 2016
-
(2011)
J. Exp. Med.
, vol.208
, pp. 2005-2016
-
-
Fuertes, M.B.1
Kacha, A.K.2
Kline, J.3
Woo, S.-R.4
Kranz, D.M.5
Murphy, K.M.6
Gajewski, T.F.7
-
19
-
-
77958012775
-
Gene signature in melanoma associated with clinical activity: A potential clue to unlock cancer immunotherapy
-
T.F. Gajewski, J. Louahed, and V.G. Brichard Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy Cancer J. 16 2010 399 403
-
(2010)
Cancer J.
, vol.16
, pp. 399-403
-
-
Gajewski, T.F.1
Louahed, J.2
Brichard, V.G.3
-
20
-
-
84886698315
-
Innate and adaptive immune cells in the tumor microenvironment
-
T.F. Gajewski, H. Schreiber, and Y.-X. Fu Innate and adaptive immune cells in the tumor microenvironment Nat. Immunol. 14 2013 1014 1022
-
(2013)
Nat. Immunol.
, vol.14
, pp. 1014-1022
-
-
Gajewski, T.F.1
Schreiber, H.2
Fu, Y.-X.3
-
21
-
-
84876032294
-
Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative
-
C.A. Gamba, S.M. Swetter, M.L. Stefanick, J. Kubo, M. Desai, K.M. Spaunhurst, A.A. Sinha, M.M. Asgari, S. Sturgeon, and J.Y. Tang Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative Cancer 119 2013 1562 1569
-
(2013)
Cancer
, vol.119
, pp. 1562-1569
-
-
Gamba, C.A.1
Swetter, S.M.2
Stefanick, M.L.3
Kubo, J.4
Desai, M.5
Spaunhurst, K.M.6
Sinha, A.A.7
Asgari, M.M.8
Sturgeon, S.9
Tang, J.Y.10
-
22
-
-
48949119467
-
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study
-
G.L. Gierach, J.V. Lacey Jr., A. Schatzkin, M.F. Leitzmann, D. Richesson, A.R. Hollenbeck, and L.A. Brinton Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study Breast Cancer Res. 10 2008 R38
-
(2008)
Breast Cancer Res.
, vol.10
, pp. R38
-
-
Gierach, G.L.1
Lacey, J.V.2
Schatzkin, A.3
Leitzmann, M.F.4
Richesson, D.5
Hollenbeck, A.R.6
Brinton, L.A.7
-
23
-
-
3142587657
-
Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression
-
A.-C. Goulet, J.G. Einsphar, D.S. Alberts, A. Beas, C. Burk, A. Bhattacharyya, J. Bangert, J.M. Harmon, H. Fujiwara, A. Koki, and M.A. Nelson Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression Cancer Biol. Ther. 2 2003 713 718
-
(2003)
Cancer Biol. Ther.
, vol.2
, pp. 713-718
-
-
Goulet, A.-C.1
Einsphar, J.G.2
Alberts, D.S.3
Beas, A.4
Burk, C.5
Bhattacharyya, A.6
Bangert, J.7
Harmon, J.M.8
Fujiwara, H.9
Koki, A.10
Nelson, M.A.11
-
24
-
-
77950346282
-
Immunity, inflammation, and cancer
-
S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
-
(2010)
Cell
, vol.140
, pp. 883-899
-
-
Grivennikov, S.I.1
Greten, F.R.2
Karin, M.3
-
25
-
-
79952284127
-
Hallmarks of cancer: The next generation
-
D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
26
-
-
84937542228
-
GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c(+)MHCII(+) macrophages and dendritic cells
-
J. Helft, J. Böttcher, P. Chakravarty, S. Zelenay, J. Huotari, B.U. Schraml, D. Goubau, and C. Reis e Sousa GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c(+)MHCII(+) macrophages and dendritic cells Immunity 42 2015 1197 1211
-
(2015)
Immunity
, vol.42
, pp. 1197-1211
-
-
Helft, J.1
Böttcher, J.2
Chakravarty, P.3
Zelenay, S.4
Huotari, J.5
Schraml, B.U.6
Goubau, D.7
Reis Sousa, E.C.8
-
27
-
-
56449097442
-
Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity
-
K. Hildner, B.T. Edelson, W.E. Purtha, M. Diamond, H. Matsushita, M. Kohyama, B. Calderon, B.U. Schraml, E.R. Unanue, M.S. Diamond, and et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity Science 322 2008 1097 1100
-
(2008)
Science
, vol.322
, pp. 1097-1100
-
-
Hildner, K.1
Edelson, B.T.2
Purtha, W.E.3
Diamond, M.4
Matsushita, H.5
Kohyama, M.6
Calderon, B.7
Schraml, B.U.8
Unanue, E.R.9
Diamond, M.S.10
-
28
-
-
84928771999
-
T cell exclusion, immune privilege, and the tumor microenvironment
-
J.A. Joyce, and D.T. Fearon T cell exclusion, immune privilege, and the tumor microenvironment Science 348 2015 74 80
-
(2015)
Science
, vol.348
, pp. 74-80
-
-
Joyce, J.A.1
Fearon, D.T.2
-
29
-
-
84855361145
-
Regulation of immune responses by prostaglandin E2
-
P. Kalinski Regulation of immune responses by prostaglandin E2 J. Immunol. 188 2012 21 28
-
(2012)
J. Immunol.
, vol.188
, pp. 21-28
-
-
Kalinski, P.1
-
30
-
-
84874595712
-
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors
-
D.A. Knight, S.F. Ngiow, M. Li, T. Parmenter, S. Mok, A. Cass, N.M. Haynes, K. Kinross, H. Yagita, R.C. Koya, and et al. Host immunity contributes to the anti-melanoma activity of BRAF inhibitors J. Clin. Invest. 123 2013 1371 1381
-
(2013)
J. Clin. Invest.
, vol.123
, pp. 1371-1381
-
-
Knight, D.A.1
Ngiow, S.F.2
Li, M.3
Parmenter, T.4
Mok, S.5
Cass, A.6
Haynes, N.M.7
Kinross, K.8
Yagita, H.9
Koya, R.C.10
-
31
-
-
33645456543
-
Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression
-
L. Kuźbicki, A. Sarnecka, and B.W. Chwirot Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression Melanoma Res. 16 2006 29 36
-
(2006)
Melanoma Res.
, vol.16
, pp. 29-36
-
-
Kuźbicki, L.1
Sarnecka, A.2
Chwirot, B.W.3
-
33
-
-
84862776855
-
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
-
H. Matsushita, M.D. Vesely, D.C. Koboldt, C.G. Rickert, R. Uppaluri, V.J. Magrini, C.D. Arthur, J.M. White, Y.-S. Chen, L.K. Shea, and et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting Nature 482 2012 400 404
-
(2012)
Nature
, vol.482
, pp. 400-404
-
-
Matsushita, H.1
Vesely, M.D.2
Koboldt, D.C.3
Rickert, C.G.4
Uppaluri, R.5
Magrini, V.J.6
Arthur, C.D.7
White, J.M.8
Chen, Y.-S.9
Shea, L.K.10
-
34
-
-
84903750131
-
Host-directed therapy of tuberculosis based on interleukin-1 and type i interferon crosstalk
-
K.D. Mayer-Barber, B.B. Andrade, S.D. Oland, E.P. Amaral, D.L. Barber, J. Gonzales, S.C. Derrick, R. Shi, N.P. Kumar, W. Wei, and et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk Nature 511 2014 99 103
-
(2014)
Nature
, vol.511
, pp. 99-103
-
-
Mayer-Barber, K.D.1
Andrade, B.B.2
Oland, S.D.3
Amaral, E.P.4
Barber, D.L.5
Gonzales, J.6
Derrick, S.C.7
Shi, R.8
Kumar, N.P.9
Wei, W.10
-
35
-
-
84893965118
-
Immune modulation in cancer with antibodies
-
D.B. Page, M.A. Postow, M.K. Callahan, J.P. Allison, and J.D. Wolchok Immune modulation in cancer with antibodies Annu. Rev. Med. 65 2014 185 202
-
(2014)
Annu. Rev. Med.
, vol.65
, pp. 185-202
-
-
Page, D.B.1
Postow, M.A.2
Callahan, M.K.3
Allison, J.P.4
Wolchok, J.D.5
-
36
-
-
84877680589
-
Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes
-
M. Pedersen, H.V.N. Küsters-Vandevelde, A. Viros, P.J.T.A. Groenen, B. Sanchez-Laorden, J.H. Gilhuis, I.A. van Engen-van Grunsven, W. Renier, J. Schieving, I. Niculescu-Duvaz, and et al. Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes Cancer Discov. 3 2013 458 469
-
(2013)
Cancer Discov.
, vol.3
, pp. 458-469
-
-
Pedersen, M.1
Küsters-Vandevelde, H.V.N.2
Viros, A.3
Groenen, P.J.T.A.4
Sanchez-Laorden, B.5
Gilhuis, J.H.6
van Engen-van Grunsven, I.A.7
Renier, W.8
Schieving, J.9
Niculescu-Duvaz, I.10
-
37
-
-
84876028848
-
Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment
-
V.T. Phan, X. Wu, J.H. Cheng, R.X. Sheng, A.S. Chung, G. Zhuang, C. Tran, Q. Song, M. Kowanetz, A. Sambrone, and et al. Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment Proc. Natl. Acad. Sci. USA 110 2013 6079 6084
-
(2013)
Proc. Natl. Acad. Sci. USA
, vol.110
, pp. 6079-6084
-
-
Phan, V.T.1
Wu, X.2
Cheng, J.H.3
Sheng, R.X.4
Chung, A.S.5
Zhuang, G.6
Tran, C.7
Song, Q.8
Kowanetz, M.9
Sambrone, A.10
-
40
-
-
84920962202
-
Molecular and genetic properties of tumors associated with local immune cytolytic activity
-
M.S. Rooney, S.A. Shukla, C.J. Wu, G. Getz, and N. Hacohen Molecular and genetic properties of tumors associated with local immune cytolytic activity Cell 160 2015 48 61
-
(2015)
Cell
, vol.160
, pp. 48-61
-
-
Rooney, M.S.1
Shukla, S.A.2
Wu, C.J.3
Getz, G.4
Hacohen, N.5
-
41
-
-
78650215449
-
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
-
P.M. Rothwell, M. Wilson, C.-E. Elwin, B. Norrving, A. Algra, C.P. Warlow, and T.W. Meade Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Lancet 376 2010 1741 1750
-
(2010)
Lancet
, vol.376
, pp. 1741-1750
-
-
Rothwell, P.M.1
Wilson, M.2
Elwin, C.-E.3
Norrving, B.4
Algra, A.5
Warlow, C.P.6
Meade, T.W.7
-
42
-
-
84912089439
-
Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells
-
B. Ruffell, D. Chang-Strachan, V. Chan, A. Rosenbusch, C.M.T. Ho, N. Pryer, D. Daniel, E.S. Hwang, H.S. Rugo, and L.M. Coussens Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells Cancer Cell 26 2014 623 637
-
(2014)
Cancer Cell
, vol.26
, pp. 623-637
-
-
Ruffell, B.1
Chang-Strachan, D.2
Chan, V.3
Rosenbusch, A.4
Ho, C.M.T.5
Pryer, N.6
Daniel, D.7
Hwang, E.S.8
Rugo, H.S.9
Coussens, L.M.10
-
43
-
-
79953151458
-
Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion
-
R.D. Schreiber, L.J. Old, and M.J. Smyth Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion Science 331 2011 1565 1570
-
(2011)
Science
, vol.331
, pp. 1565-1570
-
-
Schreiber, R.D.1
Old, L.J.2
Smyth, M.J.3
-
44
-
-
84928774156
-
The future of immune checkpoint therapy
-
P. Sharma, and J.P. Allison The future of immune checkpoint therapy Science 348 2015 56 61
-
(2015)
Science
, vol.348
, pp. 56-61
-
-
Sharma, P.1
Allison, J.P.2
-
45
-
-
27144537768
-
Novel genes associated with malignant melanoma but not benign melanocytic lesions
-
D. Talantov, A. Mazumder, J.X. Yu, T. Briggs, Y. Jiang, J. Backus, D. Atkins, and Y. Wang Novel genes associated with malignant melanoma but not benign melanocytic lesions Clin. Cancer Res. 11 2005 7234 7242
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 7234-7242
-
-
Talantov, D.1
Mazumder, A.2
Yu, J.X.3
Briggs, T.4
Jiang, Y.5
Backus, J.6
Atkins, D.7
Wang, Y.8
-
46
-
-
77953538362
-
Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer
-
W. Tian, Y. Zhao, S. Liu, and X. Li Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer Eur. J. Cancer Prev. 19 2010 288 298
-
(2010)
Eur. J. Cancer Prev.
, vol.19
, pp. 288-298
-
-
Tian, W.1
Zhao, Y.2
Liu, S.3
Li, X.4
-
49
-
-
21744459533
-
Type i interferon-associated recruitment of cytotoxic lymphocytes: A common mechanism in regressive melanocytic lesions
-
J. Wenzel, B. Bekisch, M. Uerlich, O. Haller, T. Bieber, and T. Tüting Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions Am. J. Clin. Pathol. 124 2005 37 48
-
(2005)
Am. J. Clin. Pathol.
, vol.124
, pp. 37-48
-
-
Wenzel, J.1
Bekisch, B.2
Uerlich, M.3
Haller, O.4
Bieber, T.5
Tüting, T.6
-
50
-
-
24344436369
-
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
-
G. Willimsky, and T. Blankenstein Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance Nature 437 2005 141 146
-
(2005)
Nature
, vol.437
, pp. 141-146
-
-
Willimsky, G.1
Blankenstein, T.2
-
51
-
-
84903782541
-
COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models
-
L. Xu, J. Stevens, M.B. Hilton, S. Seaman, T.P. Conrads, T.D. Veenstra, D. Logsdon, H. Morris, D.A. Swing, N.L. Patel, and et al. COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models Sci. Transl. Med. 6 2014 242ra84
-
(2014)
Sci. Transl. Med.
, vol.6
, pp. 242ra84
-
-
Xu, L.1
Stevens, J.2
Hilton, M.B.3
Seaman, S.4
Conrads, T.P.5
Veenstra, T.D.6
Logsdon, D.7
Morris, H.8
Swing, D.A.9
Patel, N.L.10
|